The potential for PCR based testing to improve diagnosis and treatment of sepsis

Current Infectious Disease Reports

Volumn 15, Issue 5, 2013, Pages 372-379

  Lyle, Ngan ^a   Boyd, John ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Antibiotics; PCR; Polymerase chain reaction; Sepsis; Septic shock

Indexed keywords

ANTIBIOTIC AGENT; PROCALCITONIN; RNA 16S;

ACINETOBACTER BAUMANNII; ANTIBIOTIC SENSITIVITY; ANTIBIOTIC THERAPY; AUTOMATED EXTERNAL DEFIBRILLATOR; BACTERIAL GROWTH; BACTERIAL INFECTION; BACTERIAL MENINGITIS; BACTERIAL PERITONITIS; BACTERIUM DETECTION; BLOOD CULTURE; COST EFFECTIVENESS ANALYSIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC ERROR; DIAGNOSTIC KIT; FOOD AND DRUG ADMINISTRATION; GOLD STANDARD; HEALTH CARE DELIVERY; HEALTH CARE QUALITY; HUMAN; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MICROBIOLOGICAL EXAMINATION; MULTIPLEX POLYMERASE CHAIN REACTION; POLYMERASE CHAIN REACTION; PROSPECTIVE STUDY; REVIEW; SEPSIS; SEPTIC SHOCK;

EID: 84884589406     PISSN: 15233847     EISSN: 15343146     Source Type: Journal    
DOI: 10.1007/s11908-013-0350-4     Document Type: Review

References (52)

1. •• Dellinger RP, Levy MM, Rhodes A, et al. Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock. Crit Care Med. 2013;41:580-637. International guidelines for the management of severe sepsis.
2. Kollef MH, Sherman G, Ward S, et al. Inadequate antimicrobial treatment of infections: a risk factor for hospital mortality among critically ill patients. Chest. 1999;115:462-74.
3. Ibrahim EH, Sherman G, Ward S, et al. The influence of inadequate antimicrobial treatment of bloodstream infections on patient outcomes in the ICU setting. Chest. 2000;118:146-55.
4. Harbarth S, Garbino J, Pugin J, et al. Inappropriate initial antimicrobial therapy and its effect on survival in a clinical trial of immunomodulating therapy for severe sepsis. Am J Med. 2003;115:529-35.
5. Garnacho-Montero J, Garcia-Garmendia JL, Barrero-Almodovar A, et al. Impact of adequate empirical antibiotic therapy on the outcome of patients admitted to the intensive care unit with sepsis. Crit Care Med. 2003;31:2742-51.
6. Kumar A, Roberts D, Wood KE, et al. Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock. Crit Care Med. 2006;34:1589-96.
7. Ferrer R, Artigas A, Suarez D, et al. Effectiveness of treatments for severe sepsis. Am J Respir Crit Care Med. 2009;180:861-6.
8. Herlitz J, Bang A, Wireklint-Sundström B, et al. Suspicion and treatment of severe sepsis. An overview of the prehospital chain of care. Scand J Trauma Resusc Emerg Med. 2012;20:42-9.
9. Nguyen HB, Corbett SW, Steele R, et al. Implementation of a bundle of quality indicators for the early management of severe sepsis and septic shock is associated with decreased mortality. Crit Care Med. 2007;35:1105-12.
10. Barochia AV, Cui X, Vitberg D, et al. Bundled care for septic shock: an analysis of clinical trials. Crit Care Med. 2010;38:668-78.
11. Puskarich MA, Trzeciak S, Shapiro NI, et al. Association between timing of antibiotic administration and mortality from septic shock in patients treated with a quantitative resuscitation protocol. Crit Care Med. 2011;39:2066-71.
12. Kumar A, Zarychanski R, Light B, et al. Early combination antibiotic therapy yields improved survival compared with monotherapy in septic shock: a propensity-matched analysis. Crit Care Med. 2010;38:1773-85.
13. Morrell M, Fraser VJ, Kollef MH. Delaying the empiric treatment of candida bloodstream infection until positive blood culture results are obtained: a potential risk factor for hospital mortality. Antimicrob Agents Chemother. 2005;49:3640-45.
14. Heffner AC, Horton JM, Marchick MR, et al. Etiology of illness in patients with severe sepsis admitted to the hospital from the emergency department. Clin Infect Dis. 2010;50:814-20.
15. Reinhart K, Bauer M, Riedemann NC, et al. New approaches to sepsis: molecular diagnostics and biomarkers. Clin Microbiol Rev. 2012;25:609-34.
16. Paolucci M, Landini MP, Sambri V. Conventional and molecular techniques for the early diagnosis of bacteraemia. Int J Antimicrob Agents. 2010;36:S6-16.
17. Lesens O. Positive surveillance blood culture is a predictive factor for secondary metastatic infection in patients with Staphylococcus aureus bacteraemia. J Infect. 2004;48:245-52.
18. Grace CJ, Lieberman J, Pierce K, et al. Usefulness of blood culture for hospitalized patients who are receiving antibiotic therapy. Clin Infect Dis. 2001;32:1651-5.
19. Rhodes J, Hyder JA, Peruski LF, et al. Antibiotic use in Thailand: quantifying impact on blood culture yield and estimates of pneumococcal bacteremia incidence. Am J Trop Med Hyg. 2010;83:301-6.
20. Heid CA, Stevens J, Livak KJ, et al. Real time quantitative PCR. Genome Res. 1996;6:986-94.
21. Mancini N, Carletti S, Ghidoli N, et al. The era of molecular and other non-culture-based methods in diagnosis of sepsis. Clin Microbiol Rev. 2010;23:235-51.
22. Shang S, Chen G, Wu Y, et al. Rapid diagnosis of bacterial sepsis with PCR amplification and microarray hybridization in 16S rRNA gene. Pediatr Res. 2005;58:143-8.
23. Kumar S, Wang L, Fan J, et al. Detection of 11 common viral and bacterial pathogens causing community-acquired pneumonia or sepsis in asymptomatic patients by using a multiplex reverse transcription-PCR assay with manual (enzyme hybridization) or automated (electronic microarray) detection. J Clin Microbiol. 2008;46:3063-72.
24. Esparcia O, Montemayor M, Ginovart G, et al. Diagnostic accuracy of a 16S ribosomal DNA gene-based molecular technique (RT-PCR, microarray, and sequencing) for bacterial meningitis, early-onset neonatal sepsis, and spontaneous bacterial peritonitis. Diagn Microbiol Infect Dis. 2011;69:153-60.
25. Aittakorpi A, Kuusela P, Koukila-Kahkola P, et al. Accurate and rapid identification of Candida spp. frequently associated with fungemia by using PCR and the microarray-based Prove-it Sepsis assay. J Clin Microbiol. 2012;50:3635-40.
26. Choi Y, Wang HY, Lee G, et al. PCR-reverse blot hybridization assay for the screening and identification of pathogens in sepsis. J Clin Microbiol. 2013;51:1451-7.
27. Kim DM, Jung SI, Jang HC, et al. Vibrio vulnificus DNA load and mortality. J Clin Microbiol. 2010;49:413-5.
28. Kirkbright S, Fatovich D, Kee C, et al. Quantitative rt-PCR holds promise as a screening tool for patients with severe sepsis. Emerg Med Australas. 2011;23:502-6.
29. Ho YC, Chang SC, Lin SR, et al. High levels of mecA DNA detected by a quantitative real-time PCR assay are associated with mortality in patients with methicillin-resistant Staphylococcus aureus bacteremia. J Clin Microbiol. 2009;47:1443-51.
30. Hackett SJ, Guiver M, Marsh J, et al. Meningococcal bacterial DNA load at presentation correlates with disease severity. Arch Dis Child. 2002;86:44-6.
31. Darton T, Guiver M, Naylor S, et al. Severity of meningococcal disease associated with genomic bacterial load. Clin Infect Dis. 2009;48:587-94.
32. Mencacci A, Leli C, Cardaccia A, et al. Procalcitonin predicts real-time PCR results in blood samples from patients with suspected sepsis. PLoS One. 2012;7:e53279.
33. Schreiber J, Nierhaus A, Braune SA, et al. Comparison of three different commercial PCR assays for the detection of pathogens in critically ill sepsis patients. Med Klin Intensivmed Notfmed. 2013;108:311-8.
34. Lehmann LE, Hunfeld K-P, Steinbrucker M, et al. Improved detection of blood stream pathogens by real-time PCR in severe sepsis. Intensive Care Med. 2009;36:49-56.
35. Westh H, Lisby G, Breysse F, et al. Multiplex real-time PCR and blood culture for identification of bloodstream pathogens in patients with suspected sepsis. Clin Microbiol Infect. 2009;15:544-51.
36. Maubon D, Hamidfar-Roy R, Courby S, et al. Therapeutic impact and diagnostic performance of multiplex PCR in patients with malignancies and suspected sepsis. J Infect. 2010;61:335-42.
37. Dark P, Chadwick P, Warhurst G. Detecting sepsis-associated bloodstream infection acquired in intensive care using multi-pathogen real-time PCR. J Infect. 2009;59:296-8.
38. Dierkes C, Ehrenstein B, Siebig S, et al. Clinical impact of a commercially available multiplex PCR system for rapid detection of pathogens in patients with presumed sepsis. BMC Infect Dis. 2009;9:126-32.
39. Tsalik EL, Jones D, Nicholson B, et al. Multiplex PCR to diagnose bloodstream infections in patients admitted from the emergency department with sepsis. J Clin Microbiol. 2010;48:26-33.
40. • Pasqualini L, Mencacci A, Leli C, et al. Diagnostic performance of a multiple real-time PCR assay in patients with suspected sepsis hospitalized in an internal medicine ward. J Clin Microbiol. 2012;50:1285-8. Largest and most recent study comparing the performance of a commercial multiplex PCR kit with that of blood cultures for the diagnosis of sepsis.
41. Tran NK, Greenhalgh DG, Palmieri TL, et al. Multiplex PCR pathogen detection in two severely burned patients with suspected septicemia. J Burn Care Res. 2011;32:e172-7.
42. •• Chuang Y-C, Chang S-C, Wang W-K. Using the rate of bacterial clearance determined by real-time polymerase chain reaction as a timely surrogate marker to evaluate the appropriateness of antibiotic usage in critical patients with Acinetobacter baumannii bacteremia. Crit Care Med. 2012;40:2273-80. An exciting proof of concept that bacterial load is associated with clinically meaningful events.
43. Bloos F, Hinder F, Becker K, et al. A multicenter trial to compare blood culture with polymerase chain reaction in severe human sepsis. Intensive Care Med. 2009;36:241-7.
44. Wolk DM, Dunne WM. New technologies in clinical microbiology. J Clin Microbiol. 2011;49:S62-7.
45. Kramer DB, Xu S, Kesselheim AS. Regulation of medical devices in the United States and European Union. N Engl J Med. 2012;366:848-55.
46. Hess AS, Shardell M, Johnson JK, et al. Methods and recommendations for evaluating and reporting a new diagnostic test. Eur J Clin Microbiol Infect Dis. 2012;31:2111-6.
47. Lehmann LE, Herpichboehm B, Kost GJ, et al. Cost and mortality prediction using polymerase chain reaction pathogen detection in sepsis: evidence from three observational trials. Crit Care. 2010;14:R186.
48. Soni NJ, Samson DJ, Galaydick JL, et al. Procalcitonin-guided antibiotic therapy. Comparative Effectiveness Review No. 78. Effective Health Care Program. AHRQ Publication No. 12(13)-EHC124-EF. Rockville, MD: Agency for Healthcare Research and Quality. 2012. www.effectivehealthcare.ahrq.gov/reports/final.cfm.
49. Schuetz P. Role of procalcitonin in managing adult patients with respiratory tract infections. Chest. 2012;141:1063-73.
50. • Waldeisen JR, Wang T, Mitra D, et al. A real-time PCR antibiogram for drug-resistant sepsis. PLoS One. 2011;6:e28528. Proof of concept that PCR technology can be used for phenotypic resistance testing.
51. Machiavelli N. The prince. Plano: Veroglyphic Publishing. 2009.
52. • Bloos F, Sachse S, Kortgen A, et al. Evaluation of a polymerase chain reaction assay for pathogen detection in septic patients under routine condition: an observational study. PLoS One. 2012;7:e46003. Compares PCR multiplex testing with blood cultures under routine clinical conditions.